According to Allogene Therapeutics 's latest financial reports the company's current revenue (TTM) is $0.09 M. In 2022 the company made a revenue of $0.24 M a decrease over the years 2021 revenue that were of $38.48 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.09 M | -60.91% |
2022 | $0.24 M | -99.37% |
2021 | $38.48 M | |
2020 | N/A | |
2019 | N/A | |
2018 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |